PharmaResources (Shanghai) Co., Ltd. (SHE:301230)

Revenue by Product

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Drug Discovery	316.57M
Drug Discovery Growth	7.97%
Commercial Production	165.21M
Commercial Production Growth	51.02%
Process Research and Development	48.16M
Process Research and Development Growth	-38.15%
Other	14.52M
Other Growth	57.21%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Foreign	407.85M
Foreign Growth	19.28%
China	136.62M
China Growth	-7.57%